The effect of papaverine on morphologic differentiation, proliferation and invasive potential of human prostatic cancer LNCaP cells
暂无分享,去创建一个
Ken Takeda | K. Takeda | T. Kitamura | K. Kawabe | Toshitaka Goto | Hisashi Matsushima | Yutaka Kasuya | Yoshio Hosaka | Tadaichi Kitamura | Kazuki Kawabe | Akino Hida | Yasuyuki Ohta | Takahisa Simizu | Y. Hosaka | H. Matsushima | T. Goto | Y. Ohta | Y. Kasuya | Akino Hida | Takahisa Simizu
[1] R. Warrell,et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1992, Cancer research.
[2] P. Greengard,et al. Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. , 1969, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Kemshead,et al. Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166). , 1987, Cancer research.
[4] E. Jaffe,et al. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells , 1987, Molecular and cellular biology.
[5] A. Bloch. Induced cell differentiation in cancer therapy. , 1984, Cancer treatment reports.
[6] K. Prasad,et al. Role of cyclic amp in differentiation of human neuroblastoma cells in culture , 1975, Cancer.
[7] J. Scott. Cyclic nucleotide-dependent protein kinases. , 1991, Pharmacology & therapeutics.
[8] J. Mulcahy,et al. Carcinoma of the prostate. , 1978, The Journal of the Kentucky Medical Association.
[9] C. Dinney,et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. , 1992, Journal of the National Cancer Institute.
[10] Y. Bang,et al. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Imashuku,et al. Characterization and activation of cyclic adenosine 3′:5′‐monophosphate‐dependent protein kinase in C1300 murine neuroblastoma clones growing in vivo , 1982, International journal of cancer.
[12] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[13] M. Ui,et al. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. , 1977, Biochemical medicine.
[14] Y. Cho‐Chung. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. , 1990, Cancer research.
[15] R. Virag. INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILURE , 1982, The Lancet.
[16] D. Friedman. Role of cyclic nucleotides in cell growth and differentiation. , 1976, Physiological reviews.
[17] Y. Bang,et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Das,et al. A rationale for the treatment of metastatic neuroblastoma. , 1976, Journal of the National Cancer Institute.
[19] S. Zimmer,et al. The effect of dibutyryl camp (dBcAMP) on morphological differentiation, growth and invasion in vitro of a hamster brain‐tumor cell line: A comparative study of dBcAMP effects in 2‐ and 3‐dimensional cultures , 1991, International journal of cancer.
[20] D M Essayan,et al. Cyclic nucleotide phosphodiesterases. , 2001, The Journal of allergy and clinical immunology.
[21] D. Peehl,et al. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. , 1993, Endocrinology.
[22] R. Vessella,et al. Inhibition of tumorigenic potential and prostate‐specific antigen expression in LNCaP human prostate cancer cell line by 13‐cis‐retinoic acid , 1994, International journal of cancer.
[23] Y. Ito,et al. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. , 1995, Cancer research.